1 / 12

Case Study 1 MICR 410 - Hematology Spring, 2011

Case Study 1 MICR 410 - Hematology Spring, 2011. HIBA ALLO CHRISTINA CASTRO CLAIRE ENDO ADRIAN VALONES. Case Summary. John, a 4 year old boy, complains of weakness, fatigue, and dyspnea (labored breathing). Parents encounter bouts of fatigue , but have never consulted a physician.

erin-love
Download Presentation

Case Study 1 MICR 410 - Hematology Spring, 2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Case Study 1MICR 410 - HematologySpring, 2011 HIBA ALLO CHRISTINA CASTRO CLAIRE ENDO ADRIAN VALONES

  2. Case Summary • John, a 4 year old boy, complains of weakness, fatigue, and dyspnea (labored breathing). • Parents encounter bouts of fatigue, but have never consulted a physician. • Parents are from Greece. • Significance: Greeks have a genetic predilection for certain diseases http://www.inmagine.com/unx202/u14837207-photo

  3. Key Information Pointing to Diagnosis • Patient presents with anemia. Weakness, fatigue, and dyspnea are symptoms of anemia. • CBC • Low RBC, Hemoglobin, and HCT  Anemia • Hypochromic, Microcytic • Peripheral Blood Smear • Poikilocytosis, Polychromasia and Target Cells (dominant) • NOTE: Target Cells are also found in Hemoglobinopathies, Iron Deficiency Anemia, & Thalassemia http://www.med.cmu.ac.th/dept/pediatrics/06-interest-cases/ic-52/case52-page-1.HTM

  4. KEY INFORMATION POINTING TO DIAGNOSIS • Additional lab test confirming the diagnosis: • Hemoglobin Electrophoresis & Iron Panel • Hemoglobin Electrophoresis Results Abnormal • HbA levels are low • 8% Hb Bart’s and 24% Hb H are abnormally present • Iron Studies are normal • α-Thalassemia is commonly found in Mediterranian people (Greeks and Sardinians)

  5. The Diagnosis for Case 1 • R/O Iron Deficiency Anemia • Iron panel normal • R/O Hemoglobinopathies & β-Thalassemia • Alpha chains decreased: low Hgb A 66% (95-98%) • β and ϒ chains in excess: Hgb H 24%, Hgb Bart’s 8% • Hgb S, SC, C: No sickle cells or crystals present • Diagnosis: Hemoglobin H Disease (Alpha Thalassemia)

  6. Pathophysiology of Hb H Disease • Patients with Deletional Hb H Disease lack 3 of the α-globin genes • Patients with Non-deletional Hb H Disease lack 2 of the α-globin genes and 1 of the present genes is abnormal • Gene deletion results in excess γ andβchains • Excess γ4 tetreamers form in the fetus • Excess β4 tetreamers form in adults • Hb H (β4) ranges from 5 to 30% of Hb in patients with the disease (24% in this case) • Hb H has a high affinity for oxygen resulting in a left shift of the O2 dissociation curve where less O2 is delivered to the tissues https://aspirusgmi.dnadirect.com/grc/patient-site/alpha-thalassemia-carrier-screening/genetics-of-alpha-thalassemia.html?w3bz10N81iH6NK6Ms-JpoqO Left Shift Abn Hb

  7. Pathophysiology of Hb H Disease • Hb H forms an intracellular precipitate • As RBCs age they contain more precipitated Hb H due to attachment to the cell membrane • Precipitates make Hb H RBCs more rigid leading to culling in the spleen • Hb H Disease is mainly a hemolytic disorder • Precipitates may also cause ineffective erythropoiesis http://emedicine.medscape.com/article/958850-overview http://bloodjournal.hematologylibrary.org/content/105/2.cover-expansion

  8. Diagnostic Tests for Hb H Disease • Hemoglobin electrophoresis is used to quantify and identify hemoglobin types • Iron Panel • Brilliant Cresyl Blue Stain can display Hb H inclusions • High Performance Liquid Chromatography can quickly separate different hemoglobins Zhou S et al. J. Biol. Chem. 2006;281:32611-32618 http://bloodjournal.hematologylibrary.org/content/105/2.cover-expansion http://www.med.cmu.ac.th/dept/pediatrics/06-interest-cases/ic-52/case52-page-1.HTM

  9. Therapy and Prognosis for Hb H Disease • Therapy • For severe anemia: blood transfusions • Monitor for Hemochromatosis • Splenectomy • Hematopoietic Stem Cell Transplantation • Requires bone marrow transplant • Only used in severe cases • Avoid certain medications sulfa drugs, analgesics • Avoid mothballs and fava beans: causes severe anemia • Prognosis • Proper care reduces medical complications • Good prognosis with treatment • Nondeletional Hb H Disease has more severe complications than Deletional Hb H Disease

  10. Prevention of Hb H Disease • Family history – genetic counseling • Likelihood of Hgb Bart’s (Hydrops Fetalis) • Prenatal Testing • Amniocentesis & Chorionic Villus Sampling • Ultrasound Monitoring of Hydrophobic Changes • Preimplantation Genetic Diagnosis (PGD) • Embryos grown in vitro • Increase chance of a healthy child

  11. Take Home Message • The diagnosis is Hemoglobin H (alpha thalassemia) • Typical symptoms • Fatigue, weakness & dyspnea • The cause of the disease • 3 Alpha chain gene deletions • Diagnostic tests • CBC, Iron Panel & Hemoglobin electrophoresis • Treatment • Intermittent blood transfusions for severe anemia • Splenectomy then bone marrow transplant in severe cases • Dietary restriction & avoiding certain medications • Prognosis • Prognosis is good with proper medical care • Prevention is genetic counseling with family history, prenatal testing & PGD

  12. References • Cheerva, A.C. and Coppes, M.J. (2011). Hemoglobin H Disease (Alpha Thalassemia). Retrieved from http://emedicine.medscape.com/article/955496-overview • Chui, D. H. K. et al. (2003). Hemoglobin H Disease: not necessarily a benign disorder. Blood, 101(3), 791-800. • Harmening, D. (2008). Clinical Hematology and Fundamentals of Hemostasis. (5th ed.). Baltimore, MD: F.A. Davis Company. • Knapp, A. et al. (2010). Evidence Review: Hemoglobin H Disease. Retrieved from http://www.hrsa.gov/heritabledisorderscommittee/reports/ hemogolbinh.pdf • London Fertility Centre. Information Sheet for Thalassemias and Preimplantation Genetic Diagnosis. Retrieved from http://www.fertilityplus.org.uk/data/documents/PGD-THALINFOSHEET74%20V4%2007%2010%2010.pdf

More Related